This digital document is an article from Transplant News, published by Transplant Communications, Inc. on December 1, 2008. The length of the article is 379 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Osiris Therapeutics completes patient enrollment in first worldwide Phase III stem cell trial.
Author: Gale Reference Team
Publication:Transplant News (Newsletter)
Date: December 1, 2008
Publisher: Transplant Communications, Inc.
Volume: 18 Issue: 12
Distributed by Gale, a part of Cengage Learning
Osiris Therapeutics completes patient enrollment in first worldwide Phase III stem cell trial.: An article from: Transplant News
📄 Viewing lite version
Full site ›
Book Details
Author(s)Gale Reference Team
PublisherTransplant Communications, Inc.
ISBN / ASINB001VMKD26
ISBN-13978B001VMKD25
AvailabilityAvailable for download now
Sales Rank99,999,999
MarketplaceUnited States 🇺🇸